Brown & Brown, Inc. (BRO)
BRO Price and Sentiment
BRO Latest news
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List.
Brown & Brown, Inc. (BRO) CEO Powell Brown on Q3 2021 Results - Earnings Call Transcript
Brown & Brown (BRO) Q3 results reflect improved organic growth and margin expansion.
Brown & Brown (BRO) delivered earnings and revenue surprises of 11.54% and 1.28%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown, Inc. announces quarterly revenues of $770.3 million, an increase of 14.3%, and diluted net income per share of $0.522021-10-25 17:00
DAYTONA BEACH, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") today announced its unaudited financial results for the third quarter of 2021.
This article series covers dividend changes on a weekly basis. A table with relevant data and key statistics of dividend increases is provided.
Brown & Brown (BRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Brown & Brown's (BRO) recent dividend hike highlights its strong financial position and constant efforts to enhance shareholders' value.
DAYTONA BEACH, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE: BRO) announces that the Board of Directors has declared a regular quarterly cash dividend of $0.1025 per share. The dividend is payable on November 17, 2021, to shareholders of record on November 3, 2021. The dividend represents a 10.8% increase from the previous regular quarterly cash dividend of $0.0925 per share and is the twenty-eighth consecutive annual dividend increase for the Company.
DAYTONA BEACH, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and the shareholders of Remedy Analytics Inc., today announced that Brown & Brown, Inc. has acquired all of the stock of Remedy Analytics.